TENAX THERAPEUTICS, INC. TENX Income Statement

Tenax therapeutics, inc. (TENX)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Oct'15	Sep'15	Jul'15	Jun'15	Mar'15	Jan'15	Oct'14	Jul'14	Jan'14	Oct'13	Jul'13	Jan'13	Oct'12	Jul'12	Apr'12	Jan'12	Oct'11	Jul'11	Jan'11	Oct'10	Jul'10
Product Revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	0	37	39	52	100	0	0	0	0	0	0
Cost of sales
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	0	20	21	22	51	0	0	0	0	0	0
Net product revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	0	17	18	29	49	0	0	0	0	0	0
Government grant revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	0	-	0	-	-	0	0	0	1,087	1,012	581	314	0	0	0	0	0	-
Total net revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	0	1,104	1,030	611	363	0	0	0	0	0	-
Operating expenses
General and administrative
4,940	5,084	5,894	6,046	5,639	5,653	6,040	6,175	5,961	5,678	2,694	2,485	3,036	6,245	-162	2,528	5,702	5,558	0	6,884	0	6,877	0	0	0	0	0	0	0	4,335	4,315	5,553	6,091	0	0	0	0	0	0
Research and development
2,611	3,471	-77	477	815	1,239	6,323	6,431	5,520	3,527	12,333	9,353	7,144	13,139	136	5,049	10,428	8,067	0	6,435	0	6,697	0	0	0	0	0	0	0	2,333	2,563	2,447	2,462	0	0	0	0	0	0
Restructuring expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	220	217	47	0	0	0	0	-	-	-
Loss on impairment of long-lived assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	29	29	29	29	0	0	0	0	0	0
Loss on impairment of long-lived assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
7,551	8,555	5,817	6,523	6,454	6,893	12,363	12,607	11,481	9,205	48,293	45,103	43,446	52,650	-1,060	6,543	16,130	13,626	0	14,355	0	14,610	0	0	0	0	0	0	0	6,918	7,126	8,078	8,583	0	0	0	0	0	0
Net operating loss
-7,551	-8,555	-5,817	-6,523	-6,454	-6,893	-12,363	-12,607	-11,481	-9,205	-48,293	-45,103	-43,446	-52,650	1,011	-6,592	-16,130	-13,626	0	-14,306	0	-14,561	0	0	0	0	0	0	0	-5,813	-6,096	-7,467	-8,220	0	0	0	0	0	0
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	0	4	0	48	0	0	0	0	0	0	0	4,377	8,897	8,902	7,412	0	0	0	0	0	0
Loss on extinguishment of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Other income
194	160	10	28	65	79	624	566	559	366	350	199	197	764	141	552	702	622	0	834	0	767	0	0	0	0	0	0	0	20	-62	-59	-80	0	0	0	0	0	0
Net loss
-7,357	-8,394	-13,137	-13,825	-13,719	-14,144	-11,739	-12,040	-10,922	-8,839	-39,981	-36,941	-35,286	-43,923	1,153	-6,040	-15,429	-13,007	0	-13,476	0	-13,842	0	0	0	0	0	0	0	-10,171	-15,056	-16,429	-15,712	0	0	0	0	0	0
Unrealized loss (gain) on marketable securities
2	0	-11	-18	-28	-16	4	6	14	-2	55	98	22	-110	-78	-130	15	-21	0	-218	0	14	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-
Total comprehensive loss
9,434	8,394	15,138	14,443	14,539	14,127	5,944	5,645	6,771	8,837	37,198	40,281	41,860	43,813	16,597	15,192	15,445	12,985	0	13,257	0	13,857	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-
Net loss
-7,357	-8,394	-13,137	-13,825	-13,719	-14,144	-11,739	-12,040	-10,922	-8,839	-39,981	-36,941	-35,286	-43,923	1,153	-6,040	-15,429	-13,007	0	-13,476	0	-13,842	0	0	0	0	0	0	0	-10,171	-15,056	-16,429	-15,712	0	0	0	0	0	0
Preferred stock dividend
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	0	0	0	0	-	-	-	-	-	-	-
Net loss attributable to common stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	0	0	0	0	-	-	-	-	-	-	-
Net loss per share, basic and diluted
-0.38	-0.41	-0.33	-0.28	-0.33	-5.87	-1.05	-1.28	-0.84	-0.95	-0.87	-2.12	-2.33	-30.73	-0.15	-0.17	-0.19	-0.09	-0.13	-0.10	-0.11	-0.17	-0.10	-	-0.14	-0.08	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average number of common shares outstanding, basic and diluted
6,974	6,768	6,741	6,385	4,887	1,920	1,462	1,453	1,422	1,411	1,411	1,411	1,406	-78,735	28,119	28,119	28,119	28,119	28,119	28,119	28,119	28,119	28,119	-	28,107	27,661	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share, basic
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.10	-	-	-0.43	-1.23	-2.06	-1.45	-0.97	-2.38	-11.62	-0.26	-0.12	-0.12	-0.11	-0.09	-0.13
Weighted average number of common shares outstanding, basic
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	28,119	-	-	10,260	4,942	2,102	1,658	1,603	1,509	-69,573	27,558	23,805	23,395	23,391	23,387	23,215
Net loss per share, diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.10	-	-	-0.44	-1.25	-3.36	-2.78	-2.63	-4.30	-13.06	-0.39	-0.29	-0.33	-0.11	-0.09	-0.13
Weighted average number of common shares outstanding, diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	28,119	-	-	10,266	4,948	2,210	1,767	1,712	1,618	-74,305	29,731	25,980	24,143	23,391	23,387	23,215